Coinfection
Coverage of the 2012 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Tuesday, 13 November 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2012) in Boston, November 9-13, 2012.
Conference highlights include treatment for hepatitis B and C, new direct-acting HCV drugs, interferon-free hepatitis C therapy, management of liver disease complications, HIV/HBV and HIV/HCV coinfection, and prevention and treatment of hepatocellular carcioma.
HIVandHepatitis.com AASLD 2012 conference section
11/13/12
AASLD 2012: Final Study Results Show Telaprevir Is Safe and Effective for HIV/HCV Coinfected Patients
- Details
- Category: HIV/HCV Coinfection
- Published on Monday, 12 November 2012 00:00
- Written by Liz Highleyman
HIV/HCV coinfected people treated with telaprevir (Incivek) triple therapy are significantly more likely to achieve sustained virological response, or a cure, than people treated with pegylated interferon/ribavirin alone, according to final results from Study 110 presented at the American Association for the Study of Liver Diseases Liver Meeting (AASLD 2012) this week in Boston.
HIV+ People Who Acquire Hepatitis C May Have Impaired HCV-specific Interferon Response
- Details
- Category: HIV/HCV Coinfection
- Published on Friday, 26 October 2012 00:00
- Written by Liz Highleyman
People who already have HIV when they become infected with hepatitis C virus (HCV) appear to have reduced production of cytokines including natural interferons active against HCV, according to a study described in the November 15, 2012, Journal of Infectious Diseases. 
Liver Meeting Highlights: New Hep C Drugs, NAFLD, Liver Cancer, Acetaminophen Toxicity, Benefits of Coffee
- Details
- Category: Hepatitis B
- Published on Monday, 12 November 2012 00:00
- Written by Liz Highleyman
The American Association for the Study of Liver Diseases Liver Meeting is the premier annual U.S. conference on 
hepatology, covering all aspects of liver disease including viral hepatitis, fatty liver, hepatocellular carcinoma, and liver transplantation. Kicking off the meeting on Saturday, AASLD President Guadalupe Garcia-Tsao offered a media overview of some highlights selected from the more than 2000 abstracts to be presented during the week.
Hepatitis C Treatment Adherence Is Important for HIV/HCV Coinfected People
- Details
- Category: HIV/HCV Coinfection
- Published on Tuesday, 16 October 2012 00:00
- Written by Liz Highleyman
Near-perfect adherence to pegylated interferon plus ribavirin offers the best chance of sustained virological response -- or a cure -- for HIV positive people coinfected with hepatitis C virus (HCV), according to a U.S. veterans study described in the August 21, 2012, advance online edition of AIDS and Behavior.
AASLD Liver Meeting Starts this Weekend in Boston
- Details
- Category: Hepatitis B
- Published on Friday, 09 November 2012 00:00
- Written by Liz Highleyman
The American Association for the Study of Liver Diseases (AASLD) annual Liver Meeting is underway, running November 9-13 at the Hynes Convention Center in Boston. The AASLD meeting each fall and the European Association for the Study of the Liver (EASL) International Liver Congress each spring are the premier events for presentation of the latest data on treatment for hepatitis B and C.
ICAAC 2012: Hepatitis C Can Be Successfully Treated in Injection Drugs Users with or without HIV
- Details
- Category: HCV Treatment
- Published on Wednesday, 10 October 2012 00:00
- Written by Liz Highleyman
HIV negative and HIV positive chronic hepatitis patients in Vancouver with a history of injection drug use -- most of whom were on methadone maintenance -- achieved sustained response rates with interferon-based therapy similar to those of non-users, researchers reported at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012) last month in San Francisco. 
Hepatitis C Incidence Rises among HIV+ Gay Men in Swiss Study
- Details
- Category: Gay & Bisexual Men/MSM
- Published on Friday, 09 November 2012 00:00
- Written by Liz Highleyman
Sexually transmitted hepatitis C virus (HCV) infection has increased dramatically over the past 13 years among gay and bisexual men in the Swiss HIV Cohort Study, even as it remained stable among heterosexuals and decreased among injection drug users, investigators reported in the November 2012 issue of Clinical Infectious Diseases.
ICAAC 2012: Infections are Common among HIV/HCV Coinfected Patients on Interferon
- Details
- Category: Side Effects - HCV
- Published on Friday, 28 September 2012 00:00
- Written by Liz Highleyman
Life-threatening infections occur frequently among people with HIV and hepatitis C virus (HCV) coinfection during treatment with pegylated interferon plus ribavirin, but this does not appear to be a consequence of neutropenia, or loss of white blood cells, according to a poster presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012) this month on San Francisco. 
Web Design and Development by